Non-nucleoside reverse transcriptase inhibitors: perspectives on novel therapeutic compounds and strategies for the treatment of HIV infection

RW Buckheit - Expert Opinion on Investigational Drugs, 2001 - Taylor & Francis
At present, the nucleoside reverse transcriptase (RT) inhibitors and protease inhibitors (PI)
have dominated the therapeutic options for the treatment of human immunodeficiency virus …
被引用次数：44 相关文章

Non-nucleoside reverse transcriptase inhibitors: perspectives on novel therapeutic compounds and strategies for the treatment of HIV infection.

RW Buckheit - Expert Opinion on Investigational Drugs, 2001 - europepmc.org
At present, the nucleoside reverse transcriptase (RT) inhibitors and protease inhibitors (PI)
have dominated the therapeutic options for the treatment of human immunodeficiency virus …

Non-nucleoside reverse transcriptase inhibitors: perspectives on novel therapeutic compounds and strategies for the treatment of HIV infection

RW Buckheit - Expert opinion on investigational drugs, 2001 - pubmed.ncbi.nlm.nih.gov
At present, the nucleoside reverse transcriptase (RT) inhibitors and protease inhibitors (PI)
have dominated the therapeutic options for the treatment of human immunodeficiency virus …